Literature DB >> 16127029

Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.

Irini A Scordi-Bello1, Arevik Mosoian, Cejiang He, Yiban Chen, Yang Cheng, Gary A Jarvis, Marla J Keller, Kathleen Hogarty, Donald P Waller, Albert T Profy, Betsy C Herold, Mary E Klotman.   

Abstract

Poly(styrene 4-sulfonate), cellulose sulfate, polymethylenehydroquinone, and PRO 2000 are sulfated or sulfonated polymers (SPs) under development as topical microbicides. They are presumed to work through similar mechanisms of action, although to date there has been no extensive comparison of their anti-human immunodeficiency virus activities. To determine whether any of these candidate microbicides offers a potential advantage, their in vitro activities, mechanisms of action, stabilities in biological secretions, and toxicities were compared. All four compounds were found to be active against X4, R5, and dualtropic primary isolates and against X4 and R5 laboratory-adapted strains in CD4+ T cells, macrophages, and single-coreceptor cell lines. Our single-cycle experiments using pseudotyped virus suggest that all four SPs function at the binding and entry stages of the viral life cycle but differ in degree of postentry effect. Surface plasmon resonance analyses demonstrate that SPs bind to X4 and R5 monomeric glycoprotein 120 with similar high binding affinities. When mixed with cervicovaginal lavage fluid, SPs maintain inhibitory activity at concentrations achievable in formulations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127029      PMCID: PMC1195443          DOI: 10.1128/AAC.49.9.3607-3615.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model.

Authors:  Dorothy L Patton; Yvonne T Cosgrove Sweeney; Lorna K Rabe; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2002-10       Impact factor: 2.830

2.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

Authors:  M Baba; O Nishimura; N Kanzaki; M Okamoto; H Sawada; Y Iizawa; M Shiraishi; Y Aramaki; K Okonogi; Y Ogawa; K Meguro; M Fujino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

3.  Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

Authors:  P Greenhead; P Hayes; P S Watts; K G Laing; G E Griffin; R J Shattock
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Efficacy and safety of a new vaginal contraceptive antimicrobial formulation containing high molecular weight poly(sodium 4-styrenesulfonate).

Authors:  Lourens J D Zaneveld; Donald P Waller; Robert A Anderson; Calvin Chany; William F Rencher; Kenneth Feathergill; Xiao-Hui Diao; Gustavo F Doncel; Betsy Herold; Morris Cooper
Journal:  Biol Reprod       Date:  2002-04       Impact factor: 4.285

5.  Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.

Authors:  M Moulard; H Lortat-Jacob; I Mondor; G Roca; R Wyatt; J Sodroski; L Zhao; W Olson; P D Kwong; Q J Sattentau
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy.

Authors:  Daniele Marras; Leslie A Bruggeman; Feng Gao; Nozomu Tanji; Mahesh M Mansukhani; Andrea Cara; Michael D Ross; G Luca Gusella; Gary Benson; Vivette D D'Agati; Beatrice H Hahn; Mary E Klotman; Paul E Klotman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

7.  Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.

Authors:  C Coggins; K Blanchard; F Alvarez; V Brache; E Weisberg; P H Kilmarx; M Lacarra; R Massai; D Mishell; A Salvatierra; P Witwatwongwana; C Elias; C Ellertson
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

8.  A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.

Authors:  L Van Damme; A Wright; K Depraetere; I Rosenstein; V Vandersmissen; L Poulter; M McKinlay; E Van Dyck; J Weber; A Profy; M Laga; V Kitchen
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

9.  Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.

Authors:  C Mauck; D H Weiner; S Ballagh; M Creinin; D F Archer; J Schwartz; H Pymar; J J Lai; M Callahan
Journal:  Contraception       Date:  2001-12       Impact factor: 3.375

10.  Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.

Authors:  A Robert Neurath; Nathan Strick; Shibo Jiang; Yun-Yao Li; Asim K Debnath
Journal:  BMC Infect Dis       Date:  2002-04-30       Impact factor: 3.090

View more
  38 in total

1.  Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.

Authors:  Onofrio Zirafi; Kyeong-Ae Kim; Nadia R Roan; Silvia F Kluge; Janis A Müller; Shibo Jiang; Benjamin Mayer; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

Review 2.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

3.  Critical design features of phenyl carboxylate-containing polymer microbicides.

Authors:  Robert F Rando; Sakae Obara; Mark C Osterling; Marie Mankowski; Shendra R Miller; Mary L Ferguson; Fred C Krebs; Brian Wigdahl; Mohamed Labib; Hiroyasu Kokubo
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Authors:  Nicola Richardson-Harman; Carol Lackman-Smith; Patricia S Fletcher; Peter A Anton; James W Bremer; Charlene S Dezzutti; Julie Elliott; Jean-Charles Grivel; Patricia Guenthner; Phalguni Gupta; Maureen Jones; Nell S Lurain; Leonid B Margolis; Swarna Mohan; Deena Ratner; Patricia Reichelderfer; Paula Roberts; Robin J Shattock; James E Cummins
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

6.  Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.

Authors:  M C Skinner; A O Kiselev; C E Isaacs; T A Mietzner; R C Montelaro; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

Review 7.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

8.  SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission.

Authors:  Theresa L Chang; Natalia Teleshova; Aprille Rapista; Maciej Paluch; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Angela Granelli-Piperno; Mary E Klotman
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

9.  A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Robert F Rando; Mohamed Labib; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2010-05-31

10.  Structure activity relationship of dendrimer microbicides with dual action antiviral activity.

Authors:  David Tyssen; Scott A Henderson; Adam Johnson; Jasminka Sterjovski; Katie Moore; Jennifer La; Mark Zanin; Secondo Sonza; Peter Karellas; Michael P Giannis; Guy Krippner; Steve Wesselingh; Tom McCarthy; Paul R Gorry; Paul A Ramsland; Richard Cone; Jeremy R A Paull; Gareth R Lewis; Gilda Tachedjian
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.